Publications

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
Aspelund T, Thornórisdóttir O, Olafsdottir E, Gudmundsdottir A, Einarsdóttir AB, Mehlsen J, Einarsson S, Pálsson O, Einarsson G, Bek T, Stefánsson E.
Diabetologia. 2011 Oct;54(10):2525-32. Epub 2011 Jul 27.
View Article (PDF)
 
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
Olafsdóttir E, Stefánsson E.
Br J Ophthalmol. 2007 Dec;91(12):1599-601. Epub 2007 Jul 12.
View Article (PDF)
 
Screening for diabetic retinopathy. Initiation and frequency.
Kristinsson JK, Gudmundsson JR, Stefánsson E, Jónasson F, Gíslason I, Thórsson AV.
Acta Ophthalmol Scand. 1995 Dec;73(6):525-8.
 
The prevalence of cataract in a population with and without type 2 diabetes mellitus.
Olafsdottir E, Andersson DK, Stefánsson E.
Acta Ophthalmol. 2012 Jun;90(4):334-40. doi: 10.1111/j.1755-3768.2011.02326.x. Epub 2011 Dec 16.
 
Risk of retinal neovascularization in the second eye in patients with proliferative diabetic retinopathy.
Vésteinsdóttir E, Björnsdóttir S, Hreidarsson AB, Stefánsson E.
Acta Ophthalmol. 2010 Jun;88(4):449-52. Epub 2009 Jul 14.
 
Prevention of diabetic retinopathy.
Einarsdóttir AB, Stefánsson E.
Lancet. 2009 Apr 18;373(9672):1316-8.
 
Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
Olafsdottir E, Andersson DK, Stefánsson E.
Acta Ophthalmol Scand. 2007 Feb;85(1):40-5.
 
Screening compliance and visual outcome in diabetes.
Zoega GM, Gunnarsdóttir T, Björnsdóttir S, Hreietharsson AB, Viggósson G, Stefánsson E.
Acta Ophthalmol Scand. 2005 Dec;83(6):687-90.
 
Prevention of diabetic blindness.
Stefánsson E.
Br J Ophthalmol. 2006 Jan;90(1):2-3.
View Article (PDF)
 
Retinal vessel caliber and diabetic retinopathy.
Stefansson E, Landers MB 3rd, Wolbarsht M.
Arch Ophthalmol. 2005 May;123(5):709.
 
Man versus machine: is technology a blessing or a barrier in screening for diabetic eye disease?
Stefánsson E.
Acta Ophthalmol Scand. 2004 Dec;82(6):643-4.
 
Screening and prevention of diabetic blindness.
Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E.
Acta Ophthalmol Scand. 2000 Aug;78(4):374-85.
 
Active prevention in diabetic eye disease. A 4-year follow-up.
Kristinsson JK, Hauksdóttir H, Stefánsson E, Jónasson F, Gíslason I.
Acta Ophthalmol Scand. 1997 Jun;75(3):249-54.
 
Retinal vessel dilatation and elongation precedes diabetic macular oedema.
Kristinsson JK, Gottfredsdóttir MS, Stefánsson E.
Br J Ophthalmol. 1997 Apr;81(4):274-8.
View Article (PDF)
 
Screening for eye disease in type 2 diabetes mellitus.
Kristinsson JK, Stefánsson E, Jónasson F, Gíslason I, Björnsson S.
Acta Ophthalmol (Copenh). 1994 Jun;72(3):341-6.
 
Systematic screening for diabetic eye disease in insulin dependent diabetes.
Kristinsson JK, Stefánsson E, Jónasson F, Gíslason I, Björnsson S.
Acta Ophthalmol (Copenh). 1994 Feb;72(1):72-8.
 
Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy.
Wilson CA, Stefánsson E, Klombers L, Hubbard LD, Kaufman SC, Ferris FL 3rd.
Am J Ophthalmol. 1988 Aug 15;106(2):131-4.